Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, aiming to provide a new FDA-approved option for smoking cessation
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, aiming to provide a new FDA-approved option for smoking cessation.